Dysthymia as a less known form of depression: clinical picture and treatment

Czech version

Authors: M. Hrdlička ^1,2
Authors‘ workplace: Dětská psychiatrická klinika 2. LF UK a FN Motol, Praha ¹; Psychologický ústav FF MU, Brno ²
Published in: Čes-slov Pediat 2021; 76 (2): 119-123.
Category: Review

Overview

A review paper presents current knowledge on dysthymia, a milder chronic form of depression. It summarizes the clinical picture and etiology of the disorder. In a pharmacotherapeutic part, it describes recommended drugs for the management of dysthymia including moclobemide, amisulpride, imipramine, sertraline, paroxetine, fluoxetine, escitalopram, bupropion, and venlafaxine. The review is supplemented by a short overview of psychotherapeutic possibilities.

Keywords:

dysthymia – depression – antidepressants – SSRI – amisulpride – psychotherapy

Sources

1. Marneros A, et al. Das Neue Handbuch der Bipolaren und Depressiven Erkrankungen. Stuttgart-New York: Georg Thieme Verlag, 2004: 781.

2. Raboch J, Zvolský P, a kol. Psychiatrie. Praha: Galén, 2001: 622.

3. Mezinárodní klasifikace nemocí, 10. revize. Duševní poruchy a poruchy chování. Diagnostická kritéria pro výzkum (přel. z angl. orig.). Praha: Psychiatrické centrum, 1996: 179.

4. Raboch J, Hrdlička M, Mohr P, Pavlovský P, Ptáček R (editoři české verze). DSM-5: Diagnostický a statistický manuál duševních poruch. Praha: Hogrefe – Testcentrum, 2015: 1032.

5. Sadock BJ, Sadock VA, Ruiz P. Kaplan & Sadock´s Synopsis of Psychiatry. Philadelphia: Wolters Kluwer, 2015: 1472.

6. Hosák L, Hrdlička M, Libiger J, a kol. Psychiatrie a pedopsychiatrie. Praha: Karolinum, 2015: 648.

7. Birmaher B, Ryan ND, Williamson DE, et al. Childhood and adolescent depression: a review of the past 10 years. Part I. J Am Acad Child Adolesc Psychiatry 1996; 35: 1427–1439.

8. Boleloucký Z, Plevová J, Smulevič AB. Hraniční stavy v psychiatrii. Praha: Grada Avicenum, 1993: 232.

9. Dulcan MK. Dulcan´s textbook of child and adolescent psychiatry. Arlington, VA: American Psychiatric Association Publishing, 2016: 1179.

10. Schramm E, Klein DN, Elsaesser M, et al. Review of dysthymia and persistent depressive disorder: history, correlates, and clinical implications. Lancet Psychiatry 2020; 7: 801–812.

11. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 2018; 391: 1357–1366.

12. Kriston L, von Wolff A, Westphal A, et al. Effícacy and acceptability of acute treatments for persistent depressive disorder: a network meta-analysis. Depress Anxiety 2014; 31: 621–630.

13. Meister R, von Wolff A, Mohr H, et al. Comparative safety of pharmacologic treatment for persistent depressive disorder: a systematic review and network metaanalysis. Plos ONE 2018; 11: e0153380.

14. Trebatická J, Šuba J. Možnosti farmakoterapie depresívnej poruchy u detí a adolescentov. Čes-slov Pediat 2019; 74: 211–214.